Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Keryx Biopharmaceuticals 

750 Lexington Avenue, 26th Floor

New York  New York  10022  U.S.A.
Phone: 212-531-5965 Fax: 212-531-5961



 Company News
Keryx Biopharmaceuticals (KERX) To Present At The 9th Annual JMP Securities Healthcare Conference 6/18/2014 9:20:09 AM
Keryx Biopharmaceuticals (KERX) Announces Issuance Of Two U.S. Patents For Zerenex(TM) Covering Orally Administrable Forms Of Ferric Citrate 6/18/2014 8:55:20 AM
Dyadic International, Inc. Appoints Michael Tarnok, Chairman Of Keryx Biopharmaceuticals (KERX) And Former Pfizer Inc. (PFE) Senior Vice President, To Board Of Directors 6/12/2014 8:18:02 AM
Keryx Biopharmaceuticals (KERX) To Present At The 35th Annual Goldman, Sachs & Co. Global Healthcare Conference 6/5/2014 9:23:00 AM
Keryx Biopharmaceuticals (KERX) Receives Notification Of PDUFA Date Extension For Zerenex™ 5/23/2014 10:10:16 AM
Keryx Biopharmaceuticals (KERX) Announces First Quarter 2014 Financial Results 5/8/2014 9:31:11 AM
New York Biotech Keryx Biopharmaceuticals (KERX) Opens Up Shop In Boston 5/7/2014 7:47:22 AM
Keryx Biopharmaceuticals (KERX) To Host Conference Call On First Quarter 2014 Financial Results 5/6/2014 9:25:52 AM
Keryx Biopharmaceuticals (KERX) Strengthens Leadership Team With Key Additions In Sales, Corporate Development And Legal 4/15/2014 9:17:33 AM
Keryx Biopharmaceuticals (KERX) Announces Zerenex™ (Ferric Citrate Coordination Complex) Phase 2 Results In Non-Dialysis Dependent Chronic Kidney Disease Selected As A Late Breaking Oral Presentation At The Upcoming National Kidney Foundation 2014 Spring Clinical Meeting 4/9/2014 7:59:05 AM